SM

Steve Mendelsohn

Director Director DIN 01959411
DIN 01959411 First appointment Sep 2006 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Sep 2006
Shareholding value Locked Premium profile

About Steve Mendelsohn

Data last updated:

Steve Mendelsohn has 20 years in corporate governance. Formerly with 1 company, such as United States Pharmacopeia - India Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 01959411
Primary Designation Director
First Appointment 28 Sep 2006
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director28 Sep 20062005Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
United States Pharmacopeia - India Private Limited
Premium access

Shareholding and investment profile for Steve Mendelsohn

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Steve Mendelsohn

Steve Mendelsohn has 20 years in corporate governance. Formerly with 1 company, such as United States Pharmacopeia - India Private Limited. Engaged in General Business. Contributes to corporate operations.

Steve Mendelsohn is associated with 0 companies as a director.

Steve Mendelsohn has expertise in General Business.

Steve Mendelsohn has 20 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available